Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster

Name: Safety and Immunogenicity of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) as a Booster
License: Public Domain

WestVac Biopharma Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

covid-19, sars-cov-2 infection

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 325156
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.